Terms: = Prostate cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC AND Treatment
52 results:
1. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
[TBL] [Abstract] [Full Text] [Related]
2. A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
Freedland SJ; Nair S; Lin X; Karsh L; Pieczonka C; Potluri R; Brookman-May SD; Mundle SD; Fleming S; Agarwal N
World J Urol; 2023 Dec; 41(12):3535-3542. PubMed ID: 37966506
[TBL] [Abstract] [Full Text] [Related]
3. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
Ngo HV; Bak HE; Nguyen HD; Lee KW; Park C; Lee BJ
Int J Nanomedicine; 2023; 18():2325-2344. PubMed ID: 37168738
[TBL] [Abstract] [Full Text] [Related]
4. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract] [Full Text] [Related]
5. Examining the effectiveness and implementation of patient treatment decision-aid tools for men with localised prostate cancer: A systematic review.
Todio E; Sharp J; Morrow A; Taylor N; Schofield P; Mazariego C
Psychooncology; 2023 Apr; 32(4):469-491. PubMed ID: 36610001
[TBL] [Abstract] [Full Text] [Related]
6. Coadministration of Apalutamide and Relugolix in Patients with Localized prostate cancer at High Risk for Metastases.
Brown G; Belkoff L; Hafron JM; Saltzstein DR; Potdar R; Bhaumik A; Phillips J; McGowan T; Shore ND
Target Oncol; 2023 Jan; 18(1):95-103. PubMed ID: 36472728
[TBL] [Abstract] [Full Text] [Related]
7. Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
Pozzar RA; Xiong N; Hong F; Filson CP; Chang P; Halpenny B; Berry DL
BMC Med Inform Decis Mak; 2022 Aug; 22(1):223. PubMed ID: 36002847
[TBL] [Abstract] [Full Text] [Related]
8. Extraction of treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With prostate cancer.
Guin S; Jun T; Patel VG; Ayers KL; Deitz M; Cai Y; Zhou X; Tsao CK; Oh WK; Chen R; Liaw BC
JCO Clin Cancer Inform; 2022 Jun; 6():e2200010. PubMed ID: 35696627
[TBL] [Abstract] [Full Text] [Related]
9. Decisional Conflict is Associated with treatment Modality and not Disease Knowledge in South African Men with prostate cancer: Baseline Results from a Longitudinal Prospective Observational Study.
Irusen H; Burger H; Fernandez PW; Van der Merwe A; Esterhuizen T; du Plessis DE; Seedat S
Cancer Control; 2022; 29():10732748221082791. PubMed ID: 35442835
[TBL] [Abstract] [Full Text] [Related]
10. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
[TBL] [Abstract] [Full Text] [Related]
11. Liproca Depot: A New Antiandrogen treatment for Active Surveillance Patients.
Klotz L; Grudén S; Axén N; Gauffin C; Wassberg C; Bjartell A; Giddens J; Incze P; Jansz K; Jievaltas M; Rendon R; Richard PO; Ulys A; Tammela TL
Eur Urol Focus; 2022 Jan; 8(1):112-120. PubMed ID: 33583762
[TBL] [Abstract] [Full Text] [Related]
12. Men's experiences of deciding about treatment for localized prostate cancer: a meta-synthesis.
Sferrazza S; Accettone R; Pampoorickel K; Caggianelli G; Casciato S; Cinque A; Matarese M
Prof Inferm; 2019; 72(4):272-282. PubMed ID: 32243742
[TBL] [Abstract] [Full Text] [Related]
13. Patient-reported Outcomes Following treatment of Localised prostate cancer and Their Association with Regret About treatment Choices.
van Stam MA; Aaronson NK; Bosch JLHR; Kieffer JM; van der Voort van Zyp JRN; Tillier CN; Horenblas S; van der Poel HG
Eur Urol Oncol; 2020 Feb; 3(1):21-31. PubMed ID: 31411965
[TBL] [Abstract] [Full Text] [Related]
14. Communicative aspects of decision aids for localized prostate cancer treatment - A systematic review.
Vromans RD; van Eenbergen MC; Pauws SC; Geleijnse G; van der Poel HG; van de Poll-Franse LV; Krahmer EJ
Urol Oncol; 2019 Jul; 37(7):409-429. PubMed ID: 31053529
[TBL] [Abstract] [Full Text] [Related]
15. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
[TBL] [Abstract] [Full Text] [Related]
16. prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
[TBL] [Abstract] [Full Text] [Related]
17. Influence of Men's Personality and Social Support on treatment Decision-Making for Localized prostate cancer.
Reamer E; Yang F; Holmes-Rovner M; Liu J; Xu J
Biomed Res Int; 2017; 2017():1467056. PubMed ID: 28785574
[TBL] [Abstract] [Full Text] [Related]
18. An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized prostate cancer.
Tammela TL; Häggman M; Ladjevardi S; Taari K; Isotalo T; Lennernäs H; Weis J; von Below C; Wassberg C; Lennernäs B; Tolf A; Axén N; Gölander CG; Ahlström H
J Urol; 2017 Dec; 198(6):1333-1339. PubMed ID: 28736321
[TBL] [Abstract] [Full Text] [Related]
19. Patient Knowledge and Qualities of treatment Decisions for Localized prostate cancer.
Daum LM; Reamer EN; Ruterbusch JJ; Liu J; Holmes-Rovner M; Xu J
J Am Board Fam Med; 2017; 30(3):288-297. PubMed ID: 28484061
[TBL] [Abstract] [Full Text] [Related]
20. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract] [Full Text] [Related]
[Next]
